greeksoup/ stock research

Xylem (XYL) FY2015 results: revenue $3.7 billion, down 6.7% on the year

Xylem Inc. (XYL) reported revenue of $3.7 billion for fiscal 2015, the year ended 31 December 2015, down 6.7% on the year before. Net income was $340 million, up 0.9%, and diluted earnings per share $1.87. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2016.

Revenue
$3.7 billion
-6.7% on the year
FY2009FY2015
Operating margin
12.3%
11.8% a year earlier
FY2009FY2015
Net income
$340 million
+0.9% on the year
FY2009FY2015
Diluted EPS
$1.87
+2.2% on the year
FY2009FY2015

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2015FY2014FY2013On the yearLast 8 years
Revenue3,6533,9163,837-6.7%
Cost of revenue2,2492,4032,338-6.4%
Gross profit1,4041,5131,499-7.2%
Gross margin38.4%38.6%39.1%
Research and development95.0104104-8.7%
Selling, general and administrative854920990-7.2%
Operating income449463363-3.0%
Operating margin12.3%11.8%9.5%
Interest expense55.054.055.0+1.9%
Pre-tax income403421298-4.3%
Income tax63.084.070.0-25.0%
Effective tax rate15.6%20.0%23.5%
Net income340337228+0.9%
Net margin9.3%8.6%5.9%
Diluted EPS$1.87$1.83$1.22+2.2%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2015FY2014FY2013On the yearLast 8 years
Operating cash flow464416324+11.5%
Capital expenditure117119126-1.7%
Free cash flow347297198+16.8%
Free cash flow margin9.5%7.6%5.2%
Cash from investing-132-86.0-199
Cash from financing-262-147-100
Depreciation and amortisation133142150-6.3%
Share-based compensation15.018.027.0-16.7%
Buybacks17913473.0+33.6%
Dividends paid10294.087.0+8.5%
Dividend per share$0.01$0.01$0.47+10.0%
Diluted shares, weighted182m184m186m-1.4%
Shares outstanding at period end178m182m185m-2.2%

Balance sheet

$ millionFY2015FY2014FY2013On the yearLast 8 years
Shareholders' equity2,0842,1272,241-2.0%
Non-controlling interest0.0n/an/a
Debt1,2741,2841,241-0.8%
Other liabilities1,2991,4221,375-8.6%
Total liabilities and equity4,6574,8334,857-3.6%
Fixed assets439461488-4.8%
Goodwill1,5841,6351,718-3.1%
Intangible assets435470488-7.4%
Cash and equivalents680663533+2.6%
Receivables749771817-2.9%
Inventory433486475-10.9%
Other assets337347338-2.9%
Total assets4,6574,8334,857-3.6%

10-K for the year ended 31 December 2015, filed 26 February 2016: the filing.